Search

Your search keyword '"Zou, Tiantian"' showing total 26 results
Start Over Author "Zou, Tiantian"
26 results on '"Zou, Tiantian"'

8. Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

Author

Hu, Beiyuan, primary, Zou, Tiantian, primary, Qin, Wei, primary, Shen, Xiaotian, primary, Su, Yinghan, primary, Li, Jianhua, primary, Chen, Yang, primary, Zhang, Ze, primary, Sun, Haoting, primary, Zheng, Yan, primary, Wang, Chao-Qun, primary, Wang, Zhengxin, primary, Li, Tian-En, primary, Wang, Shun, primary, Zhu, Le, primary, Wang, Xufeng, primary, Fu, Yan, primary, Ren, Xudong, primary, Dong, Qiongzhu, primary, and Qin, Lun-Xiu, primary

Published
2023
Full Text
View/download PDF

9. Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

Author

Hu, Beiyuan, primary, Zou, Tiantian, primary, Qin, Wei, primary, Shen, Xiaotian, primary, Su, Yinghan, primary, Li, Jianhua, primary, Chen, Yang, primary, Zhang, Ze, primary, Sun, Haoting, primary, Zheng, Yan, primary, Wang, Chao-Qun, primary, Wang, Zhengxin, primary, Li, Tian-En, primary, Wang, Shun, primary, Zhu, Le, primary, Wang, Xufeng, primary, Fu, Yan, primary, Ren, Xudong, primary, Dong, Qiongzhu, primary, and Qin, Lun-Xiu, primary

Published
2023
Full Text
View/download PDF

11. Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

Author

Hu, Beiyuan, primary, Zou, Tiantian, additional, Qin, Wei, additional, Shen, Xiaotian, additional, Su, Yinghan, additional, Li, Jianhua, additional, Chen, Yang, additional, Zhang, Ze, additional, Sun, Haoting, additional, Zheng, Yan, additional, Wang, Chao-Qun, additional, Wang, Zhengxin, additional, Li, Tian-En, additional, Wang, Shun, additional, Zhu, Le, additional, Wang, Xufeng, additional, Fu, Yan, additional, Ren, Xudong, additional, Dong, Qiongzhu, additional, and Qin, Lun-Xiu, additional

Published
2022
Full Text
View/download PDF

17. Research on Strategy of Urban Park Barrier-free Facilities Reconstruction from the Perspective of Micro-renewal——Take Huicheng District of Huizhou City as an Example

Author

Zhang Qingxin, Zou Tiantian, and Tang Hanmei

Subjects
Fair use, Quantitative analysis (finance), business.industry, Status quo, media_common.quotation_subject, Perspective (graphical), Quality (business), Landscape design, Space (commercial competition), business, Environmental planning, media_common, Disadvantaged
Abstract

The design of barrier-free facilities is an important part of paying attention to the disadvantaged groups in urban park green space, and it is the concrete embodiment of whether the whole park landscape design follows the general design principle of "creating fair use". By investigating the status quo of accessibility facilities in 11 parks and green Spaces in Huicheng District of Huizhou City, according to the types of facilities and the characteristics of users, the problems in accessibility design are proposed by combining quantitative analysis with subjective analysis. Based on the concept of micro update and upgrading strategy is put forward, which meet the demand of vulnerable groups create the public landscape space of fair use, To explore new ways to improve the green space quality of Huizhou urban parks in the future.

Published
2021

19. Lipid metabolism in cancer progression and therapeutic strategies

Author

Fu, Yan, primary, Zou, Tiantian, additional, Shen, Xiaotian, additional, Nelson, Peter J., additional, Li, Jiahui, additional, Wu, Chao, additional, Yang, Jimeng, additional, Zheng, Yan, additional, Bruns, Christiane, additional, Zhao, Yue, additional, Qin, Lunxiu, additional, and Dong, Qiongzhu, additional

Published
2020
Full Text
View/download PDF

26. The role of fenhexamid on the proliferation of ovarian cancer BG-1 cells.

Author

Fei A, Fu H, Jiang H, Wei L, Zhang H, Fei A, Zhang Y, Zou T, Gao S, Li L, Jiang H, Zhou M, Xing H, and Huang Y

Abstract

To study the influence of fenhexamid in pesticide residue to the human ovarian cancer BG-1 cell proliferation. Detecting the effectiveness of 17β-estradiol, fenhexamid and Fulvestrant to BG-1 cell proliferation by MTT, and detecting the expression levels of cyclin D1 and cyclin E by Western blot. Fenhexamid can promote BG-1 cell proliferation for its estrogen-like effect. On the other hand, it can help to improve the expression levels of cyclin D1 and cyclin E in BG-1 cells which is regulated by ER-dependent pathway. And 17β-estradiol is also regulated by the same way. The existence of fenhexamid can promote ovarian cancer cell proliferation, so for patients with ovarian cancer, fenhexamid in pesticide residue may make medical conditions worse., Competing Interests: None., (IJCEP Copyright © 2018.)

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results